Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Secura Bio Acquires Global Rights To Farydak®
Wednesday, March 13, 2019Secura Bio Inc an integrated commercialstage biopharmaceutical company dedicated to the worldwide commercialization of significant oncology therapies today announced that it has acquired the global rights to Farydak panobinostat from Novartis Fary...
HitGen and SPARC Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration
Wednesday, March 13, 2019HitGen Ltd and Sun Pharma Advanced Research Company Ltd SPARC today announced a research collaboration to identify novel small molecule leads for targets of interest Under this collaboration HitGen will apply its advanced technology platform based on...
Tenax Therapeutics Enrolls First Patient for Phase 2 Pulmonary Hypertension Clinical Trial
Tuesday, March 12, 2019Tenax Therapeutics Inc a specialty pharmaceutical company focused on identifying developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need today announced that the first patient has been r...
Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca
Tuesday, March 12, 2019Seres Therapeutics Inc announced a threeyear research collaboration with AstraZeneca The collaboration will focus on advancing mechanistic understanding of the microbiome in augmenting the efficacy of cancer immunotherapy including potential synergy...
Vitruvias Therapeutics Inc. Launches Shanghai-Based Sinotherapeutics’s Approved Version of Propafenone ER in the U.S.
Monday, March 11, 2019Vitruvias Therapeutics Inc an Auburn Alabamabased finisheddose generic drug company and Sinotherapeutics Inc a Shanghaibased generic drug company announced they have launched a bioequivalent FDAapproved version of Rythmol SR Rythmol SR known gener...
Xencor Announces Closing of Research Collaboration and License Agreement with Genentech
Monday, March 11, 2019Xencor Inc a clinicalstage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune disease asthma and allergic diseases and cancer today announced the closing of its research collaboration and license agr...
ReForm Biologics Announces Cooperation Agreement with Astellas Pharma
Friday, March 08, 2019Undisclosed pharmaceutical technology company ReForm Biologics which develops innovative biopharmaceutical manufacturing methods to improve drug delivery manufacturing today announced that Astellas Pharma Inc TSE hereinafter referred to as Astellas...
GTx and Oncternal Therapeutics Enter into Definitive Merger Agreement
Friday, March 08, 2019GTx Inc and Oncternal Therapeutics Inc a privately held clinicalstage biotechnology company developing potential firstinclass therapeutic candidates for cancers with critical unmet medical need today jointly announced that they have entered into a de...
Pacira to Acquire MyoScience, Adding FDA-approved ioveraº System for Non-opioid Pain Control
Thursday, March 07, 2019Pacira Pharmaceuticals Inc and MyoScience Inc a privately held medical technology company today announced the signing of a definitive agreement for the acquisition of MyoScience by Pacira MyoScience currently markets the iovera system a novel FDAappr...
Ambrx and BeiGene Announce Global Research and Development Collaboration to Develop Next-Generation Biologics
Thursday, March 07, 2019Ambrx Inc a clinicalstage biopharmaceutical company focused on the development of innovative protein therapeutics and BeiGene Ltd a commercialstage biopharmaceutical company focused on developing and commercializing innovative molecularlytargeted and...
